Gladys Corrons-Bouis is Business Development Director at EVEON. She started her career in the pharmaceutical industry in regulatory affairs and market access for orphan drugs. In 2007, she joined CEA to help with the maturation and licensing-out of CEA’s portfolio of drug candidates. She then participated in the creation of Avenium Consuting in 2009 and became a partner in this intellectual property strategy and business intelligence consulting firm. For 10 years, Ms Corrons-Bouis helped start-ups, small to medium enterprises, and big pharma companies, to define their industrial property strategy and consolidate their technology portfolio.
Ms Corrons-Bouis also contributed to the structuring of consulting activity and solution selling within Becton Dickinson’s Preanalytical Systems division. Since 2019, she has been developing EVEON’s commercial activity by forging key co-development partnerships with pharmaceutical companies. Ms Corrons-Bouis holds a Pharm D and a degree in Regulatory Affairs and Market Access.